STAT1h
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...
My antidepressants left me with no feeling in my genitals
Daryl Brown, who was prescribed the antidepressant Seroxat in childhood because of his Tourette’s syndrome and OCD, tells ...
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Gov. Holcomb to lead U.S. delegation to Greece
Governor Eric J. Holcomb says he will lead an international trip to Greece next week at the invitation of the Council of ...
Lilly Wachowski to Adapt Dystopian Horror About Trans People Hunting Feral Men for Survival
Trans horror enthusiasts, rejoice: Lilly Wachowski is working on a TV adaptation of Manhunt, Gretchen Felker-Martin ’s hit ...
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Hoodline6h
Michigan Attorney General Fights to Revoke Decades-Old Rulings Shielding Pharma Giant Eli Lilly from Insulin Pricing Scrutiny
Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...
WBIW7h
Governor appoints Dave Ricks to Purdue Board of Trustees
Indiana Gov. Eric Holcomb has appointed David A. Ricks to the Purdue University Board of Trustees, effective Jan. 1, 2025, to ...
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.
Ibj.com8h
Why Lilly is pouring billions into LEAP
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And ...
Top WA provider for minor gender reassignment procedures previously fined $5 million
A Washington-based surgery center ranked by a nonprofit among the top in the state for minor gender reassignment surgeries ...